Efficacy and Safety Study of Fosmetpantotenate (RE-024) in PKAN Participants

Clinical trial NCT03041116 · TERMINATED

Trial details

NCT number: NCT03041116
Sponsor: Travere Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Pantothenate Kinase-Associated Neurodegeneration

Start date: 2017-07-17
Primary completion: 2019-12-30
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.